US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Related articles
Tamara Ecclestone is criticised as her daughter Fifi, 10, heads out wearing heavy make
Tamara Ecclestone has been criticised after her 10-year-old daughter Fifi headed out wearing heavy m2024-05-22Donetsk: Deadly blast hits market in Russia
By Oliver Slow for BBC NewsPeople sell vegetables and other goods next to a bomb shelter at a market2024-05-22Scrapping NZ battery project 'short
The Lake Onslow battery project was tipped to cost $16 billion. Photo:2024-05-22Millions of donkeys killed each year to make medicine
By Victoria Gill and Kate Stephens for the BBCThree donkeys drawing a cart in Kenya. Photo: The Donk2024-05-22Analysis: Larson enters conversation with Verstappen as best drivers in the world
INDIANAPOLIS (AP) — Ask almost any hardcore motorsports fan who the best driver in the world is righ2024-05-22Hamas weighs ceasefire proposal
By Dan Williams and Nidal al-Mughrabi for ReutersIsrael's Defence Minister Yoav Gallant speaks durin2024-05-22
atest comment